Skip to main content

Trachoma vaccine field trials in The Gambia

  • Shiona Sowa (a1), J. Sowa (a1), L. H. Collier (a1) and W. A. Blyth (a1)

The ability of two live trachoma vaccines to protect against naturally acquired infection was tested in young Gambian children. With a mineral oil adjuvant vaccine prepared from a Gambian strain of trachoma (MRC–187) a barely significant measure of protection was demonstrable 6 months after the first dose, but not at 1 year, despite a reinforcing dose given 6 months after the first. In a later trial an aqueous vaccine prepared from the ‘fast-killing’ variants of strains ‘SA–2’ and ‘ASGH’ failed to induce immunity. Two years after vaccination, the proportion of vaccinated children progressing to cicatricial trachoma was less than in the controls, and the average severity of the disease in terms of clinical score was greater; vaccine-induced hypersensitivity may have contributed to this result.

Irrespective of whether they had received trachoma vaccine, children with completely normal eyes at the outset were less likely to acquire trachoma than those with slight conjunctival folliculosis or papillary hyperplasia. In children acquiring trachoma, there was a highly significant positive correlation between severity of the disease and the presence of conjunctival inclusions. The pattern of trachoma differed significantly in the two villages used in both trials; the prev alence, severity and proportion of inclusion-positive subjects were all higher in the village with the greater population density.

An efficient follow-up organization, use of a slit-lamp for clinical observations, and a scoring system for recording physical signs are all desirable for trachoma vaccine field trials.

We are highly indebted to Dr G. Turner (Lister Institute, Elstree, Herts) for his assistance in making the vaccine used for Trial II; to Dr N. M. Lam (Pfizer Ltd.) and Dr C. H. Smith (Evans Medical Ltd.) for making the Trial III vaccine; to Dr I. A. Sutherland (M.R.C. Statistical Unit) for his advice and help with the statistical aspects; to the Pennsylvania Refinery Co. Inc. for a generous gift of Drakeol 6 VR; and to Mr M. Race for his invaluable technical assistance in The Gambia. We are also grateful to the Director and staff of the M.R.C. Laboratories, The Gambia, for various facilities; and to The Gambian Government for per mission to undertake these trials.

Hide All
Bell S. D. & Theobald B. (1962). Differentiation of trachoma strains on the basis of inmnmization against toxic death of mice. Ann. N.Y. Acad. Sci. 98, 337.
Berlin B. S. (1962). Tests for biologic safety of Arlacel A. Ann. Allergy 20, 472.
Bovanick M. R., Miller J. C. & Snyder J. C. (1950). The influence of certain salts, amino acids, sugars and proteins on the stability of rickettsiae. J. Bact. 59, 509.
Collier L. H. (1961). Experiments with trachoma vaccines: experimental system using inclusion blennorrhoea virus. Lancet i, 795.
Collier L. H. (1966). The present status of trachoma vaccination studies. Bull. Wid Hlth Org. 34, 233.
Collier L. H. & Blytr W. A. (1966 a). Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells. J. Hyg., Camb. 64, 513.
Collier L. H. & Blyth W. A. (1966 b). Immunogenicity of experimental trachoma vaccines in baboons. II. Experiments with adjuvants, and tests of cross-protection. J. Hyg., Camb. 64, 529.
Collier L. H., Blytti W. A., Labin N. M. & Treharne J. (1967). Immunogenicity of experimental trachoma vaccines in baboons. III. Experiments with inactivated vaccines. J. Hyg., Camb. 65, 97.
Collier L. H. & MoGG A. (1969). Dissemination and immunogenicity of live TRIC agents in baboons after parenteral injection. II. Experiments with a ‘slow-killing’ strain. J. Hyg., Camb. 67, 449.
Collier L. H. & Smith A. (1967). Dissemination and immunogenicity of live TRIO agents in baboons after parenteral injection. Am. J. Ophthal. 63, 1589.
Collier L. H., Sowa S., Sowa J. & Blyth W. (1963). Experiments with trachoma vaccines: therapeutic effect on established trachoma. Orient. Archs Ophthal. 1, 67.
Conference On Trachoma And Allied Diseases, Sab Francisco. (1967). Am. J. Ophthal. 63, No. 5 part II.
Dulbecco R. & VOGT M. (1954). Plaque formation and isolation of pure lines with polio myolitis viruses. J. exp. Med. 99, 167.
Fisher R. A. (1958). In Statistical Methods for Research Workers, 13th ed., p. 96. Edited by Crew R. A. E.. Edinburgh: Oliver and Boyd Ltd.
Fullton F. & Dumbell K. R. (1949). The serological comparison of strains of influenza virus. J. yen. Microbiol. 3, 97.
Ftmxxss G., Graham D. M. & Reeve P. (1960). The titration of trachoma and inclusion blennorrhoea viruses in cell cultures. J. yen. Microbiol. 23, 613.
Graham D. M. (1967). Growth and immunogenicity of TRIC agents in mice. Am. J. Ophthal. 63, 1173.
Gtjerra P., Buogo A., Mabubini E. & Grnoirs M. (1967). Analysis of clinical and labora tory data of an experiment with trachoma vaccine in Ethiopia. Am. J. Ophthal. 63, 1631.
Hanna L., Jawetz E., Thygeson P. & Dawson C. (1960). Trachoma viruses isolated in United States. I. Growth in embryonated eggs. Proc. Soc. exp. Biol. Med. 104, 142.
Mordhorst C. H. (1967). Experimental infections and immunogenicity of TRIO agents in monkeys. Am. J. Ophthal. 63, 1603.
Murray E. S., Bell S. D. Jr, Hanna A. T., Nichols R. L. & Snyder J. C. (1960). Studies on trachoma. 1. Isolation and identification of strains of elementary bodies from Saudi Arabia and Egypt. Am. J. trop. Med. Hyg. 9, 116.
Nichols R. L., Bobb A. A., Haddad N. A. & Mccomb D. E. (1967). Immunofluorescent studies of the microbiologic epidemiology of trachoma in Saudi Arabia. Am. J. Ophthal. 63, 1372.
Reeve P. & Taverne J. (1962). A simple method for total particle counts of trachoma and inclusion blennorrhoea viruses. Nature, Lond. 195, 923.
Reeve P. & Taverne J. (1963). Observations on the growth of trachoma and inclusion blennorrhoea virus in embryonate eggs. J. Hyg., Camb. 61, 67.
Reeve P. & Taverns J. (1967). An assessment of the evidence for regarding the Tang strain as an authentic TRIO agent. Am. J. Ophthal. 63, 1437.
Snyder J. C., Nichols R. L., Bell S. D. Jr, Itaddad N. A., Murray E. S. & Mccomb D. E. (1964). Vaccination against trachoma in Saudi Arabia: design of field trials and initial results. Indian trop. Hlth 5, 65.
Sowa S., Sowa J., Collier L. H. & Blyth W. (1965). Trachoma and allied infections in a Gambian village. Spec. Rep. Ser. med. Res. Coun. no. 308.
Tarizzo M. L., Nabli B. & Labonne J. (1968). Studies on trachoma. II. Evaluation of laboratory diagnostic methods under field conditions. Bull. Wid Hith Org. 38, 897.
Wang S. P., Grayston J. T. & Alexander E. R. (1967). Trachoma vaccine studies in monkeys. Am. J. Ophthal. 63, 1615.
Woolridge R. L., Grayston J. T., Chang I. H., Cheng K. H., Yang C. Y. & Neave C. (1967). Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am. J. Ophthal. 63, 1645.
World Health Organization (1962). Expert Committee on Trachoma: Third Report. Tech. Rep. Ser. Wld Hlth Org. no. 234.
World Health Organization (1966). Fourth Scientific Group on Trachoma Research. Tech. Rep. Ser. Wid Hlth Org. no. 330.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 2 *
Loading metrics...

Abstract views

Total abstract views: 85 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd November 2017. This data will be updated every 24 hours.